Lung Cancer Clinical Trial
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer
Summary
The purpose of this trial is to study the efficacy and safety of the triplet combination of TLK286, carboplatin and paclitaxel as first-line therapy for patients with advanced non-small cell lung cancer.
Eligibility Criteria
Inclusion Criteria:
18 years of age or older
Histologically confirmed non-small cell lung cancer (NSCLC)
Stage IV or IIIB (disease that is not eligible for combined modality chemotherapy and radiation)
Measurable disease by RECIST
ECOG status of 0-1
Adequate liver and renal function
Adequate bone marrow reserves
Exclusion Criteria:
Prior chemotherapy, immunotherapy or biologic therapy for metastatic NSCLC
Up to one prior adjuvant or neoadjuvant chemotherapy is allowed
History of bone marrow transplantation or stem cell support
Pregnant or lactating women
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 46 Locations for this study
Concord California, 94520, United States
Concord California, 94520, United States
Escondido California, 92025, United States
Hayward California, 94545, United States
Murrieta California, 92562, United States
Oakland California, 94611, United States
Poway California, 92064, United States
Sacramento California, 95825, United States
San Francisco California, 94115, United States
San Jose California, 95119, United States
Santa Clara California, 95051, United States
So. San Francisco California, 94080, United States
Vallejo California, 94589, United States
Walnut Creek California, 94520, United States
Walnut Creek California, 94596, United States
Crystal River Florida, 34429, United States
Inverness Florida, 34452, United States
Inverness Florida, 34452, United States
Kansas City Kansas, 66112, United States
Lenexa Kansas, 66214, United States
Overland Park Kansas, 66210, United States
Shreveport Louisiana, 71101, United States
Shreveport Louisiana, 71103, United States
Baltimore Maryland, 21201, United States
Bethesda Maryland, 20817, United States
Boston Massachusetts, 02114, United States
Boston Massachusetts, 02115, United States
Boston Massachusetts, 02115, United States
Boston Massachusetts, 02115, United States
Kansas City Missouri, 64111, United States
Kansas City Missouri, 64131, United States
Kansas City Missouri, 64154, United States
Lee's Summit Missouri, 64064, United States
St. Louis Missouri, 63141, United States
Washington Missouri, 63090, United States
Scottsbluff Nebraska, 69361, United States
Scottsbluff Nebraska, 69361, United States
Fargo North Dakota, 58103, United States
Fargo North Dakota, 58104, United States
Clarksville Tennessee, 37043, United States
Franklin Tennessee, 37067, United States
Hermitage Tennessee, 37076, United States
Lebanon Tennessee, 37087, United States
Murfreesboro Tennessee, 37130, United States
Nashville Tennessee, 37203, United States
Nashville Tennessee, 37205, United States
Nashville Tennessee, 37207, United States
Nashville Tennessee, 37211, United States
Smyrna Tennessee, 37167, United States
Dallas Texas, 75231, United States
Plano Texas, 75093, United States
Danville Virginia, 24541, United States
How clear is this clinincal trial information?

Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.